Advertisement

Topics

AETERNA ZENTARIS INC. Company Profile

09:39 EDT 21st September 2018 | BioPortfolio

Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women’s health. We are engaged in drug development activities and in the promotion of products for others. The focus of our business development efforts is the acquisition of licenses to products that are relevant to our therapeutic areas of focus. We also intend to license out certain commercial rights of internally developed products to licensees in territories where such out-licensing would enable us to ensure development, registration and launch of our product candidates. Our goal is to become a growth-oriented specialty biopharmaceutical company by pursuing successful development and commercialization of our product portfolio, achieving successful commercial presence and growth, while consistently delivering value to our shareholders, employees and the medical providers and patients who will benefit from our products. For more information, visit www.aezsinc.com.


News Articles [23 Associated News Articles listed on BioPortfolio]

Comparing AEterna Zentaris

AEterna Zentaris and AC Immune are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analys...

Aeterna Zentaris Appoints Olaf Althaus as General Manager and Managing Director of Aeterna Zentaris GmbH

CHARLESTON, S.C., May 31, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) announced that Olaf Althaus has been appointed to the position of General Manager and Managing Dire...

Aeterna Zentaris Files Management Information Circular

CHARLESTON, S.C., April 09, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) is pleased to announce that it has filed its Management Information Circular for the upcoming A...

Aeterna Zentaris Provides Update on Previously Disclosed Class Action Lawsuit

CHARLESTON, S.C., March 05, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (the “Company” or “Aeterna Zentaris”)  (NASDAQ:AEZS) and (TSX:AEZS) announced today that the United States Dist...

Aeterna Zentaris Announces Results of Annual and Special Shareholders’ Meeting

CHARLESTON, S.C., May 08, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) announced today at its annual and special shareholders’ meeting held on May 8, 2018, that the ind...

Aeterna Zentaris Reports First Quarter 2018 Financial and Operating Results

CHARLESTON, S.C., May 07, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) today reported financial and operating results for the first quarter ended March 31, 2018. All A...

Aeterna Zentaris Reports Second Quarter 2018 Financial and Operating Results

CHARLESTON, S.C., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS), a biopharmaceutical company engaged in developing and commercializing pharmaceutical products,...

Aeterna Zentaris Appoints James Clavijo as Chief Financial Officer

CHARLESTON, S.C., March 05, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) today announced the appointment of James Clavijo as Chief Financial Officer effective March 5, ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

AETERNA ZENTARIS INC.

Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women’s health. We are eng...

AEterna Zentaris

Committed to cure by discovering and developing innovative drugs for the treatment of patients suffering from some forms of cancer, endocrinian disorders and infectious diseases, this is our mission. ...

Æterna Zentaris Inc

The Æterna Zentaris group is comprised of healthcare-oriented companies evolving predominantly in the biopharmaceutical as well as personal care industries. Its success depends upon scientific and cl...

AEterna Laboratories Incorporated

Æterna Laboratories Inc. is a biopharmaceutical company focused on the treatment of cancer. The company’s lead product, Neovastat®, is the focus of a number of clinical trials including pivotal tr...

More Information about "AETERNA ZENTARIS INC." on BioPortfolio

We have published hundreds of AETERNA ZENTARIS INC. news stories on BioPortfolio along with dozens of AETERNA ZENTARIS INC. Clinical Trials and PubMed Articles about AETERNA ZENTARIS INC. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AETERNA ZENTARIS INC. Companies in our database. You can also find out about relevant AETERNA ZENTARIS INC. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record